Comparative, Single-Dose, 2-Way Cross-Over Bioavailability Study of Two Olanzapine 10 Mg Tablet Formulations in Healthy Volunteers Under Fasting Conditions
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Emilija Atanasovska
Department of Preclinical and Clinical Pharmacology & Toxicology, Faculty of Medicine,
University “Ss. Cyril and Methodius”Skopje, Republic of North Macedonia
Krume Jakjovski
Department of Preclinical and Clinical Pharmacology & Toxicology, Faculty of Medicine,
University “Ss. Cyril and Methodius”Skopje, Republic of North Macedonia
Kristina Pavlovska
Department of Preclinical and Clinical Pharmacology & Toxicology, Faculty of Medicine,
University “Ss. Cyril and Methodius”Skopje, Republic of North Macedonia
Kalina Gjorgjievska
Department of Preclinical and Clinical Pharmacology & Toxicology, Faculty of Medicine,
University “Ss. Cyril and Methodius”Skopje, Republic of North Macedonia
Dimche Zafirov
Department of Preclinical and Clinical Pharmacology & Toxicology, Faculty of Medicine,
University “Ss. Cyril and Methodius”Skopje, Republic of North Macedonia
Dragica Zendelovska
Department of Preclinical and Clinical Pharmacology & Toxicology, Faculty of Medicine,
University “Ss. Cyril and Methodius”Skopje, Republic of North Macedonia
Marija Petrushevska
Department of Preclinical and Clinical Pharmacology & Toxicology, Faculty of Medicine,
University “Ss. Cyril and Methodius”Skopje, Republic of North Macedonia
Nikola Labachevski
Department of Preclinical and Clinical Pharmacology & Toxicology, Faculty of Medicine,
University “Ss. Cyril and Methodius”Skopje, Republic of North Macedonia